BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6094035)

  • 1. On the role of superoxide anion radicals in skin tumour promotion.
    Schwarz M; Peres G; Kunz W; Fürstenberger G; Kittstein W; Marks F
    Carcinogenesis; 1984 Dec; 5(12):1663-70. PubMed ID: 6094035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of reactive oxygen in tumor promotion: implication of superoxide anion in promotion of neoplastic transformation in JB-6 cells by TPA.
    Nakamura Y; Colburn NH; Gindhart TD
    Carcinogenesis; 1985 Feb; 6(2):229-35. PubMed ID: 2982513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular and biochemical changes during multistage skin tumor promotion.
    Slaga TJ; Butler AP
    Princess Takamatsu Symp; 1983; 14():291-301. PubMed ID: 6394592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetic effects caused by phorbol ester tumor promoters in primary mouse keratinocyte cultures: correlation with the convertogenic activity of TPA in multistage skin carcinogenesis.
    Petrusevska RT; Fürstenberger G; Marks F; Fusenig NE
    Carcinogenesis; 1988 Jul; 9(7):1207-15. PubMed ID: 3383339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of tumor promoter-induced chemiluminescence in mouse epidermal cells by several inhibitors of arachidonic acid metabolism.
    Fischer SM; Adams LM
    Cancer Res; 1985 Jul; 45(7):3130-6. PubMed ID: 2988761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour-promoting and hyperplastic effects of phorbol and daphnane esters in CD-1 mouse skin and a synergistic effect of calcium ionophore with the non-promoting activator of protein kinase C, sapintoxin A.
    Brooks G; Evans AT; Aitken A; Evans FJ
    Carcinogenesis; 1989 Feb; 10(2):283-8. PubMed ID: 2912580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phorbol diacetate inhibits superoxide anion radical production and tumor promotion by mezerein.
    Czerniecki B; Gad SC; Reilly C; Smith AC; Witz G
    Carcinogenesis; 1986 Oct; 7(10):1637-41. PubMed ID: 3019585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multistage tumor promotion in skin.
    Marks F; Fürstenberger G
    Princess Takamatsu Symp; 1983; 14():273-87. PubMed ID: 6440893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of DNA strand breaks with accelerated terminal differentiation in mouse epidermal cells exposed to tumor promoters.
    Hartley JA; Gibson NW; Zwelling LA; Yuspa SH
    Cancer Res; 1985 Oct; 45(10):4864-70. PubMed ID: 4027973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a biomimetic superoxide dismutase on complete and multistage carcinogenesis in mouse skin.
    Egner PA; Kensler TW
    Carcinogenesis; 1985 Aug; 6(8):1167-72. PubMed ID: 3926337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical comparison of histological and morphometric changes in SENCAR mouse epidermis in response to n-dodecane, 12-O-tetradecanoylphorbol-13-acetate and mezerein.
    Miller ML; Andringa A; Baxter CS
    Carcinogenesis; 1988 Nov; 9(11):1959-65. PubMed ID: 3180333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-stage tumorigenesis in mouse skin: DNA synthesis as a prerequisite for the conversion stage induced by TPA prior to initiation.
    Kinzel V; Fürstenberger G; Loehrke H; Marks F
    Carcinogenesis; 1986 May; 7(5):779-82. PubMed ID: 3084118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of both stage I and stage II mouse skin tumour promotion by retinoic acid and the dependence of inhibition of tumor promotion on the duration of retinoic acid treatment.
    Verma AK
    Cancer Res; 1987 Oct; 47(19):5097-101. PubMed ID: 3621194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the mechanism of skin tumor promotion: evidence for several stages in promotion.
    Slaga TJ; Fischer SM; Nelson K; Gleason GL
    Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3659-63. PubMed ID: 6774342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eicosanoids and multistage carcinogenesis in NMRI mouse skin: role of prostaglandins E and F in conversion (first stage of tumor promotion) and promotion (second stage of tumor promotion).
    Fürstenberger G; Gross M; Marks F
    Carcinogenesis; 1989 Jan; 10(1):91-6. PubMed ID: 2910536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition by lipoxygenase inhibitors of 7-bromomethylbenz[a]anthracene-caused epidermal ornithine decarboxylase induction and skin tumor promotion in mice.
    Nakadate T; Yamamoto S; Aizu E; Kato R
    Carcinogenesis; 1989 Nov; 10(11):2053-7. PubMed ID: 2553289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. alpha-Difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits tumor promoter-induced polyamine accumulation and carcinogenesis in mouse skin.
    Weeks CE; Herrmann AL; Nelson FR; Slaga TJ
    Proc Natl Acad Sci U S A; 1982 Oct; 79(19):6028-32. PubMed ID: 6821130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of nitroblue tetrazolium reduction in mouse peritoneal macrophages by tumour promoters and inhibition of the induced nitroblue tetrazolium reduction by some inhibitors.
    Ohkawa Y; Iwata K; Shibuya H; Inui N
    Cancer Lett; 1985 Jul; 27(3):261-7. PubMed ID: 2990669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-tumor promoting action of phthalic acid mono-n-butyl ester cupric salt, a biomimetic superoxide dismutase.
    Yamamoto S; Nakadate T; Aizu E; Kato R
    Carcinogenesis; 1990 May; 11(5):749-54. PubMed ID: 2110512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential inhibition by staurosporine, a potent protein kinase C inhibitor, of 12-O-tetradecanoylphorbol-13-acetate-caused skin tumor promotion, epidermal ornithine decarboxylase induction, hyperplasia and inflammation.
    Yamamoto S; Kiyoto I; Aizu E; Nakadate T; Hosoda Y; Kato R
    Carcinogenesis; 1989 Jul; 10(7):1315-22. PubMed ID: 2544313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.